| Previous Close | 0.2100 |
| Open | 0.2100 |
| Bid | 0.2100 x N/A |
| Ask | 0.2150 x N/A |
| Day's Range | 0.2100 - 0.2100 |
| 52 Week Range | 0.1800 - 0.3700 |
| Volume | 5,000 |
| Avg. Volume | 22,076 |
| Market Cap | 9.009M |
| Beta (5Y Monthly) | -0.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0450 |
| Earnings Date | Dec. 13, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Sep. 26, 2008 |
| 1y Target Est | N/A |
- CNW Group
Cymat Provides Business Update "Getting Back on Track"
Listing:Â TSX-V Symbol: CYMTORONTO, Sept. 8, 2020 /CNW/ -Â Today Cymat Technologies Ltd.
- Simply Wall St.
Should Cymat Technologies (CVE:CYM) Be Disappointed With Their 52% Profit?
While Cymat Technologies Ltd. (CVE:CYM) shareholders are probably generally happy, the stock hasn't had particularly...
- CNW Group
Cymat Announces Reliance on Interim Financial Statement Filing Extension
TORONTO , March 31, 2020 /CNW/ - Cymat Technologies Ltd. (the "Company" or "Cymat") announces that pursuant to the blanket relief granted by the Canadian Securities Administrators it will not be filing its interim financial statements for the quarter ended January 31, 2020 , and the related management's discussion and analysis, as required by Parts 4 and 5 of National Instrument 51-102 - Continuous Disclosure Obligations (collectively, the "Interim Filings") by the filing deadline of March 31, 2020 . The Company expects to report results on or about April 30, 2020 , and is afforded a postponement up to a maximum 45-day extension pursuant to blanket relief for all market participants granted by the Canadian Securities Administrators. Other than as disclosed in the Company's press releases, there have not been any material business developments since the date of that the last interim financial statements of the Company were filed.
